Investing

Sugar prices have climbed by nearly 40% so far this year, on track to mark their best yearly performance in…

The Nasdaq-100 is heading down lately after a decent 2023 rally that seemed to fade as the summer turned into…

By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects…

Key News Asia was a sea of red except for Mainland China and Hong Kong following US tech’s drawdown and…

By Sabela Ojea Boston Scientific said its clinical trial to treat coronary in-stent restenosis with its investigational device met its…

The Federal Reserve appears virtually certain to keep rates on hold at their November 1 interest rate announcement. That’s according…

By Ben Glickman Innovation Beverage Group now plans to sell 1.2 million units in its initial public offering, compared with…

U.S. Treasury Savings bonds may be familiar to long-term investors. The Series I bond is one type of government issued…

By Josh Beckerman Energy Recovery shares were down 17% Wednesday after the company said Chief Executive Bob Mao departed but…

If you don’t like these 10% and 12% dividends, well, you’re not really an income investor. That’s right. As I…